Dibucaine ointment

Closed Solicitation Posted

Solicitation number
SPE2DP27T0077
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
Not on record

Notice details come from DLA DIBBS. Updated .

About this opportunity

DLA Troop Support Medical is soliciting quotes through DLA office SPE2DP for Dibucaine Ointment (NSN 6505-00-299-9535) under RFQ SPE2DP27T0077, with quotes due October 14, 2026. The request uses no set-aside, and quotes must be submitted through DIBBS.

The requirement is line 0001 for two packages of Dibucaine Ointment USP at 1% active ingredient, packaged in collapsible tubes with rectal applicators, with a one-ounce (28-gram) unit of issue. Delivery is required within 20 calendar days to USNS Richard E. Byrd (ship-to N23194, FPO AP 96661) on FOB Destination terms, with inspection and acceptance at destination under FAR 52.246-2. The product is FDA-regulated and carries a 36-month non-extendable shelf-life requirement. Compliance terms include DFARS 252.225-7001 Buy American and Balance of Payments Program requirements and hazard warning label requirements under DFARS 252.223-7001. The manufacturer is The Harvard Drug Group, L.L.C. (CAGE 1LEZ0).

The solicitation is a Fast Auto Evaluation RFQ that incorporates the DLA Master Solicitation for Automated Simplified Acquisitions (Revision 105, May 20, 2026). Automated award is possible unless first article test requirements apply. Historical awards for the same item went to CAGE 3W8H0 at unit prices from $6.50 to $7.62. The notice carries PSC 6505 (Drugs and Biologicals) and was posted October 9, 2026.

Notice text

DLA request for quotation SPE2DP27T0077, issued by DLA office SPE2DP through DIBBS. Quotes are due by 10/14/2026. Set-aside: No Set-Aside Used. Solicitation type: Fast Auto Evaluation. FOB Destination. Inspection at Destination. Item: line 0001, DIBUCAINE OINTMENT, NSN 6505-00-299-9535, 2 PG, delivery in 20 days, PR 7018659600. Quotes must be submitted via DIBBS.

Files

File Type Posted
SPE2DP27T0077.pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
Lidocaine GEL Medical Supply Chain No set-aside
Lidocaine GEL Medical Supply Chain No set-aside
Lidocaine hydrochlori and 2 more items Medical Supply Chain No set-aside
Analgesic GEL, topical Medical Supply Chain No set-aside
Bupivacaine and epine Medical Supply Chain No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors